Skip to main content
logo
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
27.06
-1.30 (-4.57%)
Aug 5, 2026, 1:18 PM EDT - Market open

Beam Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,7032,8202,0742,2222,7885,450
Market Cap Growth
47.28%35.99%-6.66%-20.29%-48.85%16.60%
Enterprise Value
1,8141,7291,3851,2051,8894,632
Last Close Price
27.0627.7224.8027.2239.1179.69

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
17.7820.1832.655.8845.76105.12
PB Ratio
2.422.282.832.263.806.59
P/TBV Ratio
2.632.212.782.143.736.19
P/OCF Ratio
----123.75-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
11.6312.3821.803.1931.0089.34

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.220.110.200.160.230.17
Net Debt / Equity Ratio
-0.85-0.88-0.94-1.04-1.23-0.99
Net Debt / EBITDA Ratio
2.553.021.756.502.772.13
Net Debt / FCF Ratio
2.433.031.945.5634.037.23
Asset Turnover
0.110.110.050.270.040.05
Quick Ratio
14.2512.854.675.794.825.93
Current Ratio
14.5713.094.825.894.895.96
Return on Equity (ROE)
-7.41%-8.11%-43.94%-15.46%-37.06%-69.13%
Return on Assets (ROA)
-26.37%-29.69%-32.42%-12.47%-23.72%-40.75%
Return on Invested Capital (ROIC)
-206.86%-400.72%-9926.54%---1260.55%
Return on Capital Employed (ROCE)
-28.11%-33.28%-38.20%-14.88%-28.45%-48.74%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-16.32%-20.16%-6.69%-10.19%-9.01%-37.43%
Total Shareholder Return
-16.32%-20.16%-6.69%-10.19%-9.01%-37.43%
SEC Filings: 10-K · 10-Q